Share

CEU 2020 Preview: Acromegaly Update

Patients with acromegaly provide a unique challenge to endocrine clinicians. Shlomo Melmed, MB, ChB, discusses the latest breakthroughs in treating these patients which includes newly approved pharmaceuticals in his session, “Update on Acromegaly: Treatment Based on the New Guidelines.” This year, the Endocrine Society’s Clinical Endocrinology Update (CEU) will take place online as the COVID-19...
Share

ENDO Online 2020 Preview: The Year in Pituitary

When the Endocrine Society launches ENDO Online 2020 in June, attendees will be treated to Mirjam Christ-Crain, MD, PhD, from the University of Basel, Switzerland, who will discuss the top pituitary research studies in her session, “The Year in Pituitary: Clinical and Research Breakthroughs.” For such a miniscule structure, the pea-sized hypophysis plays an outsized...
Share

Eureka 2019: A New Look at Pituitary Tumors

For the fifth year in a row, Endocrine News spoke with editors from Endocrine Society journals to get the scoop on the top endocrine discoveries of 2019. Here is part 8 of Eureka! 2019. From April, “DNA Methylation of Tumor Suppressor Genes in Pituitary Neuroendocrine Tumors,” by Picó, A., et. al. was selected by The...
Share

I Am Endocrinology: Dogs, Cats, and the Pituitary

ROB FOWKES (ENDO Council elections) I wasn’t really very aware of my own … hormones, that is. But by the time I was studying human biology at Oxford Brookes University, I knew that hormones were what I found most interesting, probably because of a combination of having a gun-toting cell physiology professor and a Chilean pharmacologist with a wonderful voice who...
Share

Positive Top-Line Results Announced from the Pivotal Phase 3 SONICS Study of Levoketoconazole for the Treatment of Endogenous Cushing’s Syndrome

Positive top-line results this week were announced from the multinational, pivotal Phase 3 SONICS study evaluating levoketoconazole for the treatment of endogenous Cushing’s syndrome. Strongbridge Biopharma is marketing the drug as RECORLEV™ . The open-label, single-arm SONICS study achieved statistical significance of its pre-specified primary endpoint, with 30 percent of patients achieving normalization of mean urinary...
Share

Endocrine Society Issues Hypothalamic Amenorrhea Guideline

Female athletes and women who have eating disorders are prone to developing a condition called hypothalamic amenorrhea that causes them to stop menstruating. The Endocrine Society today issued a Clinical Practice Guideline advising healthcare providers on ways to diagnose and treat this condition. The guideline, titled “Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline,”...